Back

Improving adherence to medicines of secondary prevention - results of a prospective multicenter follow-up study

19 April 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Cardiovascular pharmacology Pharmacology and Pharmacotherapy, Other EAPC Premium Access EuroPrevent 2018

4 More presentations in this session

Presentation thumbnail
Cardiovascular pharmacology - Poster discussant:
Presentation thumbnail
Adverse effects of drug therapy (the first results of the study according to the outpatient register)
Doctor Y. Lukina (Moscow, RU)
Abstract Slides
Presentation thumbnail
Alirucumab in cardiac rehabilitation patients. Clinical profile and initial results.
Doctor A. Rojas Sanchez (Malaga, ES)
Abstract Slides
Presentation thumbnail
Statins and risk biomarkers for coronary heart disease (CHD) in type 2 diabetes mellitus patients with normal LDL cholesterol levels. 1 year prospective study in Constanta County, Romania
Professor I. Parepa (Constanta, RO)
Abstract

Access the full session

Session thumbnail
Poster Session 3 - Cardiovascular pharmacology

The Event

Event poster

EuroPrevent 2018

19 April - 21 April 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources